fampridine News
Most Popular fampridine Story
Acorda reports positive results on MS drug
Acorda Therapeutics registered positive results from a late-stage trial of a new drug under review for approval to treat multiple sclerosis. Researchers said that slightly more than a third of the... Read more...
Latest Headlines
- October 15, 2009
- October 14, 2009
- October 9, 2009
- July 1, 2009
- April 23, 2009
- March 31, 2009
- February 27, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
